The REMEDIES (RE-configuring MEDIcines End-to-end Supply Project is headed up by GlaxoSmithKline with research led by the University of Cambridge’s Institute for Manufacturing.

Launched in 2014, REMEDIES is a broad-based collaboration examining how the multi-billion pound global medicines manufacture and supply sector can be reshaped to meet the needs, expectations and budgets of the 21st Century.

REMEDIES brings together academics, regulators and healthcare professionals alongside teams from global pharmaceutical companies, major contract manufacturing organisations, equipment manufacturers and international logistics specialists, to scrutinise the many different elements of the medicines end-to-end supply chain – from patent to patient.

The project has been funded by its industry partners and the UK Government’s Advanced Manufacturing Supply Chain Initiative.

For more information on the REMEDIES project and partner organisations, please visit the following website,